- Home
- LKSP vs SGMO Comparison
LKSP vs SGMO Comparison
Compare LKSP & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$0.33
Company Overview
Basic Information| Metric | LKSP | SGMO |
|---|---|---|
| Founded | 2024 | 1995 |
| Country | United States | United States |
| Employees | 2 | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.1M | 141.2M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | LKSP | SGMO |
|---|---|---|
| Price | $10.02 | $0.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 33.6K | ★ 4.5M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 66.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,567,000.00 |
| Revenue This Year | N/A | $4.79 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $293.18 | ★ N/A |
| Revenue Growth | N/A | ★ 88.60 |
| 52 Week Low | $9.90 | $0.32 |
| 52 Week High | $10.05 | $0.88 |
Technical Indicators
Market Signals| Indicator | LKSP | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 57.25 | 36.95 |
| Support Level | $9.90 | N/A |
| Resistance Level | $10.03 | $0.56 |
| Average True Range (ATR) | 0.01 | 0.03 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 40.00 | 15.03 |
Price Performance
Historical Comparison LKSP
SGMO
About LKSP Lake Superior Acquisition Corp. Class A Ordinary Shares
Lake Superior Acquisition Corp is a blank check company.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.